BTKi
Showing 26 - 50 of 53
LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- (no location specified)
Sep 19, 2023
Waldenstrom's Disease, Prognostic Index Trial in France
Not yet recruiting
- Waldenstrom's Disease
- Prognostic Index
-
Amiens, France
- +14 more
Jun 12, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023
Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)
Recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
MEOI and HRQoL in CLL Patients Treated With BTKis
Recruiting
- Chronic Lymphocytic Leukemia
-
Fountain Valley, California
- +15 more
Jan 16, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 20, 2023
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)
Available
- Leukemia, Lymphocytic, Chronic, B-Cell
- +4 more
-
Stanford, California
- +61 more
Aug 17, 2022
Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin's Lymphoma
- Allogenic CD19-CAR-γδT cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Jan 31, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,
Recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Zilovertamab vedotin
- Nemtabrutinib
-
Spokane, Washington
- +1 more
Aug 12, 2022
Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,
Withdrawn
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- +8 more
- Ibrutinib
- Quality-of-Life Assessment
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 2, 2022
Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non-hodgkin Lymphoma,B Cell
- Autologous CD19-STAR-T cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Zanubrutinib Pill
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022
Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +
Recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
- Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
-
Wuhan, Hubei, ChinaUnion Hospital, Huazhong University of Science and Technology
Oct 13, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Los Angeles, California
- +142 more
Jan 10, 2023
B-cell Lymphoma Trial (Orelabrutinib tablet, Lenalidomide)
Not yet recruiting
- B-cell Lymphoma
- Orelabrutinib tablet
- Lenalidomide
- (no location specified)
Aug 23, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Phoenix, Arizona
- +116 more
Jun 27, 2022
Untreated Chronic Lymphocytic Leukemia Trial in France (Stop ACA, ACA Continuation)
Recruiting
- Untreated Chronic Lymphocytic Leukemia
- Stop ACA
- ACA Continuation
-
Angers, France
- +31 more
Feb 7, 2022
Relapsed/Refractory B-cell Lymphoma Trial in France (CC-292 + lenalidomide)
Completed
- Relapsed/Refractory B-cell Lymphoma
- CC-292 + lenalidomide
-
Créteil, France
- +5 more
Mar 6, 2018
Cardiovascular Complications of Ibrutinib Therapy
Not yet recruiting
- Ibrutinib Treatment
- ophthalmological examination
- blood test
-
Dijon, FranceChu Dijon Bourgogne
Jul 3, 2023